Doxycycline Hyclate Tablet, Delayed Release
Product Images NDC 69668-515

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Doxycycline Hyclate (NDC 69668-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sonoma Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

69668515 Label (69668515)

Label for Soloxide 150 DR delayed-release tablets, containing 150 mg of doxycycline hyclate per tablet. The label indicates 30 tablets in the package, labeled Rx only. Distributed by Sonoma Pharmaceuticals, Inc., the label includes storage instructions, lot number E18C36, expiration date 11/2019, and barcode.*

FDA Label Image

Structure (Spl Image1 Structure)

Chemical structure of doxycycline hyclate showing its molecular components including hydroxyl groups, carbonyl groups, amide, and dimethylamine substituents along with its hydrochloride, ethanol, and water hydration forms as labeled.*

FDA Label Image

150 mg Treatment (Spl Image2 150mg Treatment)

Illustration showing a delayed-release tablet of Doxycycline Hyclate 150 mg from top and side views, including a side view of the tablet held between two thumbs and index fingers. The tablet is oblong with scoring and marked with the imprint 'P 0 1'.*

FDA Label Image

100 mg Treatment (Spl Image3 100mg Treatment)

Illustrative diagram showing Doxycycline Hyclate 150 mg delayed-release tablet from multiple perspectives: a top view highlighting the tablet's imprint 'P O', a side view displaying tablet thickness and shape, and a side view with two-thirds of the tablet held between a person's thumbs and index fingers.*

FDA Label Image

50 mg Treatment (Spl Image4 50mg Treatment)

An instructional illustration showing a delayed-release doxycycline hyclate tablet. The image provides three views: top view displaying the letter 'P' on the tablet, side view of the tablet shape, and a one-third size side view with a thumb and index finger holding the tablet, likely demonstrating proper handling or size perception.*

FDA Label Image

Image Description (Spl Image5 150mg Treatment)

Illustration showing three views of a Doxycycline Hyclate 150 mg delayed release tablet. The top view shows the tablet marked with "P 0 1," the side view displays the tablet's thickness and score lines, and the third view depicts a person holding the tablet between thumb and index finger horizontally.*

FDA Label Image

Image Description (Spl Image6 100mg Treatment)

Illustrations of a Doxycycline Hyclate 150 mg delayed-release oral tablet showing the tablet from a top view and a side view. An additional illustration demonstrates the tablet being held between thumbs and index fingers, highlighting its size approximately two-thirds the side view.*

FDA Label Image

Image Description (Spl Image7 50mg Treatment)

An instructional illustration showing doxycycline hyclate 150 mg delayed-release tablet. Includes a top view displaying the letter 'P' on the tablet, a side view outlining the tablet's shape, and a demonstration of the tablet's size held between a thumb and index finger, visible at one-third actual size.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.